Skip to main content
logo
PCI Biotech Holding ASA (OSL:PCIB)
Norway flag Norway · Delayed Price · Currency is NOK
0.0700
0.00 (0.00%)
Inactive · Last trade price on Apr 24, 2026

PCI Biotech Holding ASA Financials Overview

Millions NOK. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Revenue
4.696.742.994.756.277.37
Revenue Growth
-30.39%125.25%-37.05%-24.28%-14.86%-21.55%
Gross Profit
4.696.742.994.756.277.37
Operating Income
-21.63-17.96-22.24-56.45-86.03-82.12
Net Income
-20.54-16.42-20.32-55.1-88.39-72.24
Earnings Per Share
-0.55-0.44-0.54-1.48-2.37-1.94
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Investments
13.6226.6940.856.6116.12187.97
Total Debt
0.280.340.320.771.910.67
Net Cash (Debt)
13.3426.3640.4855.83114.21187.29
Net Cash Growth
-49.41%-34.89%-27.49%-51.12%-39.02%-27.94%
Net Cash Per Share
0.360.711.081.503.065.02

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Cash Flow
-15.82-13.76-14.97-59.04-68.31-77.39
Capital Expenditures
-0.63----0.34-3.92
Free Cash Flow
-16.45-13.76-14.97-59.04-68.65-81.31
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-461.46%-266.59%-743.85%-1188.36%-1371.42%-1114.55%
Pretax Margin
-438.10%-243.76%-679.43%-1159.89%-1409.07%-980.44%
Profit Margin
-438.10%-243.76%-679.43%-1159.89%-1409.07%-980.44%
FCF Margin
-350.83%-204.28%-500.67%-1242.99%-1094.34%-1103.56%

Valuation
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingSep '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
PS Ratio
0.566.5826.1516.1182.77141.34